Maravai LifeSciences completes planned CEO succession; Martin becomes CEO, Hull Executive Chairman

MARAVAI LIFESCIENCES HOLDINGS, INC.

William 'Trey' Martin, III named CEO effective July 27, 2023; previously President of Biologics Safety Testing segment.
Carl Hull transitions from interim CEO to Executive Chairman; annual base salary reduced to $500,000.
Hull's target annual bonus set at 100% of salary for 2024+; 2023 target remains $757,667.
Martin's compensation unchanged from his prior role as President of Biologics Safety Testing.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

William 'Trey' Martin, III

Chief Executive Officer

MRVI · MARAVAI LIFESCIENCES HOLDINGS, INC.

Effective: 2023-07-27
Filed: July 27, 2023, 7:59 PM ET

On July 27, 2023, William “Trey” Martin, III assumed the role of Chief Executive Officer (“CEO”) of Maravai LifeSciences Holdings, Inc.

Role change

Carl W. Hull

Executive Chairman

MRVI · MARAVAI LIFESCIENCES HOLDINGS, INC.

Effective: 2023-07-27
Successor: William 'Trey' Martin, III
Filed: July 27, 2023, 7:59 PM ET

Concurrently with the appointment of Mr. Martin as CEO, Carl W. Hull ceased to serve as interim CEO of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

William 'Trey' Martin, III was appointed as Chief Executive Officer at MARAVAI LIFESCIENCES HOLDINGS, INC..

Action: assumed
Role: Chief Executive Officer

Exact text from the filing

On July 27, 2023, William “Trey” Martin, III assumed the role of Chief Executive Officer (“CEO”) of Maravai LifeSciences Holdings, Inc.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Carl W. Hull changed role as Executive Chairman at MARAVAI LIFESCIENCES HOLDINGS, INC..

Action: ceased
Role: Executive Chairman

Exact text from the filing

Concurrently with the appointment of Mr. Martin as CEO, Carl W. Hull ceased to serve as interim CEO of the Company.

View on SEC.gov

MARAVAI LIFESCIENCES HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001823239-23-000077

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.